BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025
• 2026

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 6
• 7
• 8
• 9
• 10
• 13
• 14
• 15
• 16
• 17
• 20
• 21
• 22
• 23
• 24
• 27
• 28
• 29
• 30
• 31

• Who Will Say ‘No’ to Excessive Medical Procedures?

  July 8, 2009

   · 

  1 min read
• Business

  OSI Pharmaceuticals, Inc. to Consolidate US Operations at New Site

  July 8, 2009

   · 

  3 min read
• Biotech Bay

  Zosano Pharma, Inc. Secures $30 Million in New Round of Financing

  July 8, 2009

   · 

  3 min read
• Business

  AstraZeneca PLC to Further Develop Targacept, Inc.'s ADHD Drug; Targacept Eligible to Get Over $100 Million

  July 8, 2009

   · 

  1 min read
• Business

  NexMed, Novartis Corporation End Phase 3 Anti-Fungal Drug Development

  July 8, 2009

   · 

  2 min read
• Job Trends

  Gilead Sciences, Inc. to Create 30 Jobs in Cork, Ireland

  July 8, 2009

   · 

  1 min read
• Drug Development

  Biogen Idec, Inc. (Massachusetts) Receives Fast Track Designation from FDA for PEGylated Interferon Beta-1a for Relapsing Multiple Sclerosis

  July 8, 2009

   · 

  1 min read
• Drug Development

  Transdel Pharmaceuticals, Inc. Completes Enrollment in Phase 3 Clinical Study for Novel Topical Pain Treatment

  July 8, 2009

   · 

  4 min read
• Biotech Beach

  Fate Therapeutics to Present Data on Stimulation of Osteogenic Activity Using Small Molecule Modulators of Wnt Pathway

  July 8, 2009

   · 

  2 min read
• Policy

  Eisai Corporation of North America Release: FDA Accepts sNDA for Alternative Dosing Regimen for Dacogen(R) (decitabine for injection) to Treat Patients with Myelodysplastic Syndromes (MDS)

  July 8, 2009

   · 

  3 min read